ALPHARETTA, Ga., Sept. 6, 2017 /PRNewswire/ -- Halyard Health
(NYSE: HYH), a medical technology company focused on
eliminating pain, speeding recovery and preventing infection, today
announced the introduction of five new COOLIEF* Multi-Cooled RF
Kits for use in performing COOLIEF Cooled Radiofrequency (RF)
treatments. The new kits expand upon the four existing COOLIEF
Multi-Cooled RF Kits by offering different component lengths and
active tip sizes to treat additional modalities with our
multi-probe kits. These kits allow physicians to ablate up to three
nerves at once, saving time and the inconvenience of having to open
multiple kits and components.
The new COOLIEF Multi-Cooled RF Kits have been developed to
target nerves within the spine and knee. Each kit is equipped with
all the components necessary to conduct a multi-probe COOLIEF
Cooled RF treatment including the new COOLIEF* Fluid Delivery
Introducer (FDI). The FDI enables fluids to be instilled through
the port so that the physician can maintain probe placement and
reduce instances of repositioning. The five new
configurations of COOLIEF Multi-Cooled RF Kits include:
- MCK2-17-50-2 (Cervical): 2 Probes, 4 Introducers, 2 Tube
Kits
- MCK2-17-50-4 (Knee): 2 Probes, 4 Introducers, 2 Tube Kits
- MCK2-17-75-2 (Cervical): 2 Probes, 4 Introducers, 2 Tube
Kits
- MCK2-17-75-5.5 (Thoracic): 2 Probes, 4 Introducers, 2 Tube
Kits
- MCK3-17-50-4 (Knee): 3 Probes, 6 Introducers, 2 Tube Kits
"The addition of these five new multi-probe kits more than
doubles the number of COOLIEF Multi-Cooled RF Kits available to
pain physicians," said Phil Cranmer,
associate marketing director, Interventional Pain Management,
Halyard Health. "Rather than having to piece together multiple kits
and components, the COOLIEF Multi-Cooled RF Kit provides everything
they need to perform multiple lesions simultaneously in one
cost-effective package based on the type of procedure
required."
COOLIEF Cooled RF is the first and only treatment to receive
clearance from the U.S. Food and Drug Administration (FDA) for the
relief of chronic moderate to severe knee pain caused by
osteoarthritis (OA). COOLIEF Cooled RF is a minimally-invasive and
non-surgical outpatient procedure to target and treat the nerves
causing chronic pain. This advanced thermal radiofrequency pain
management system uses water-cooled technology to safely deactivate
pain-causing sensory nerves. COOLIEF Cooled RF has been shown to
provide up to 24 months of pain relief, improved physical
functionality, and reduced drug utilization.
To learn more about COOLIEF Cooled RF, please visit
http://www.halyardhealth.com/chronicpain.
About Halyard Health
Halyard Health Inc. (NYSE: HYH) is a medical technology company
focused on eliminating pain, speeding recovery and preventing
infection for healthcare providers and their
patients. Headquartered in Alpharetta, Georgia, Halyard is committed to
addressing some of today's most important healthcare needs, such as
reducing the use of opioids while helping patients move from
surgery to recovery and preventing healthcare-associated
infections. Halyard's business segments - Medical Devices and
Surgical and Infection Prevention (S&IP) - develop, manufacture
and market clinically superior solutions that improve medical
outcomes and business performance in more than 100 countries. For
more information, visit www.halyardhealth.com.
*Registered Trademarks or Trademarks of Halyard Health, Inc. or
its affiliates.
View original content with
multimedia:http://www.prnewswire.com/news-releases/halyard-health-introduces-five-new-coolief-multi-cooled-rf-kits-300514195.html
SOURCE Halyard Health, Inc.